title: [Evaluation of tadalafil for the treatment of erectile dysfunction].
abstract: Tadalafil is an oral phosphodiesterase type-5 inhibitor for male erectile dysfunction (ED). It has been proved to improve erectile function, with safety and effectiveness lasting up to 36 h, allowing patients to choose when to have sexual activities. Tadalafil is also efficacious in the treatment of ED associated with such diseases as hypertension, diabetes mellitus, etc. This article reviews the available evidence for the efficacy of tadalafil on ED and related diseases.
authors.affiliation: Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
authors.forename: Zhi-Yong
authors.initials: ZY
authors.lastname: Liu
authors.forename: Ying-Hao
authors.initials: YH
authors.lastname: Sun
mesh_terms: D002243:Carbolines / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D000068581:Tadalafil; D016896:Treatment Outcome
chemical_list: D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil